8-K: Biote Corp. Settles Litigation with Stockholder, Repurchases Shares for $60 Million

Biote Corp. has entered into a settlement agreement to repurchase shares from a stockholder, Marci M. Donovitz, for $60 million, resolving a litigation matter.

Summary

• Biote Corp. has finalized a settlement agreement with stockholder Marci M. Donovitz, resolving the Donovitz Litigation.
• The agreement involves the repurchase of all of Donovitz's Paired Interests (Holdings Units and Class V Shares) and Class A Shares for a total of $60 million.
• The repurchase will occur in four tranches: $30 million for approximately 4.1 million shares on June 28, 2024, and $10 million each for approximately 1.4 million shares on or before the 12, 24, and 36-month anniversaries of the closing date.
• The average price per share for the repurchased shares is $7.23.
• Additionally, approximately 4.0 million Paired Interests subject to earnout provisions owned by Donovitz will be released and cancelled without additional payment.
• The settlement includes a mutual release of claims, a voting agreement, and acceleration of the purchase schedule in the event of a change of control.

Sentiment

Score: 6

Explanation: The settlement resolves a legal issue and includes a share repurchase, which is generally positive. However, the significant cash outlay and cancellation of earnout provisions temper the overall sentiment.

Positives

• The settlement resolves the Donovitz Litigation, removing a potential legal overhang.
• The share repurchase program may be viewed positively by the market as it reduces the number of outstanding shares.
• The agreement includes a mutual release of claims, reducing future legal risks.
• The voting agreement provides clarity on shareholder voting rights.

Negatives

• The company is spending $60 million to repurchase shares, which could be seen as a significant cash outlay.
• The cancellation of 4.0 million Paired Interests subject to earnout provisions may have an impact on future potential dilution.

Risks

• The financial impact of the $60 million share repurchase could affect the company's cash reserves.
• The settlement terms, including the voting agreement, could have unforeseen consequences.
• The acceleration of the purchase schedule in the event of a change of control could create additional financial obligations.

Future Outlook

The company will file the full Settlement Agreement in its next quarterly report on Form 10-Q.

Management Comments

• The company has entered into a Settlement Agreement with Marci M. Donovitz to resolve the Donovitz Litigation.

Industry Context

Share repurchases are a common method for companies to return value to shareholders and can be used to resolve disputes with investors. This action is specific to Biote Corp. and its situation with a particular shareholder.

Comparison to Industry Standards

• Share repurchases are a common practice in the market, but the specific terms and conditions of this agreement are unique to Biote Corp.
• The average price of $7.23 per share is specific to this transaction and cannot be directly compared to other companies' share repurchases without further context.
• The settlement agreement is a unique situation and not directly comparable to other companies' legal settlements.

Legal Proceedings

• The company has settled the Donovitz Litigation through a settlement agreement.

Stakeholder Impact

• Shareholders may view the share repurchase positively, potentially increasing the value of their holdings.
• The settlement resolves a legal issue, reducing uncertainty for stakeholders.

Next Steps

• The company will complete the remaining share repurchases over the next three years.
• The full Settlement Agreement will be filed in the next quarterly report on Form 10-Q.

Key Dates

Keywords

settlement, share repurchase, litigation, stockholder, Paired Interests, Class A Shares, voting agreement, biote corp